Peter Diamandis’ right hand man Sergey Young wants to reverse aging via his $100M Longevity Vision Fund

by Natalie GroverEnvelope — on February 4, 2019 09:00 AM EST In­spired by British bil­lion­aire Jim Mel­lon, chair­man of anti-aging up­start biotech ven­ture Ju­ve­nes­cence, Sergey Young un­veiled a $100 mil­lion fund on Mon­day to cat­alyze the de­vel­op­ment of a com­pre­hen­sive so­lu­tion to coun­ter­act the dam­ag­ing con­se­quences of aging. “I’ve never looked like my ageand with my name, I think it was pre­de­ter­mined that I was going to work in the space (of aging),” Young told End­points News. The 47-year-old con­sid­ers him­self a prod­uct of Peter Dia­man­dis — the man be­hind the non-profit XPRIZE and ven­ture cap­i­tal fund BOLD Cap­i­tal Part­ners — and is in charge of all things longevity at both or­ga­ni­za­tions. Like Mel­lon, who penned Ju­ve­nes­cence: In­vest­ing in the Age of Longevity prior to the launch of the com­pany Ju­ve­nes­cence, Young is in the em­bry­onic stage of writ­ing his own book de­signed to de­code the sci­ence of aging for the masses. Mean­while, his $100 mil­lion Longevity Vi­sion Fund will back or­ga­ni­za­tions who are work­ing on tech­nol­ogy to re­verse the aging process and pro­long healthy human life. “Adding 20 to 30 healthy years on a per­son’s life is likely to be the largest mar­ket op­por­tu­nity on earth. Read more here >>>

thumbnail courtesy of


Please enter your comment!
Please enter your name here